Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as an adjuvant to ropivacaine in femoral nerve block for ACL reconstruction
ChiCTR-IPR-15006646Phase 4Recruiting
- Sponsor
- Peking University Third Hospital Department of Anesthesiology
- Start
- Jul 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anterior cruciate ligament injury comparing Dexmedetomidine group with Ropivacaine control group (2 arms). Primary endpoint: VAS score. Started Jul 2015; status: recruiting.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
anterior cruciate ligament injury
Beyond the preview
Go deeper on ChiCTR-IPR-15006646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006646.